AU2019225972B2 - Variants of porcine trypsin - Google Patents

Variants of porcine trypsin Download PDF

Info

Publication number
AU2019225972B2
AU2019225972B2 AU2019225972A AU2019225972A AU2019225972B2 AU 2019225972 B2 AU2019225972 B2 AU 2019225972B2 AU 2019225972 A AU2019225972 A AU 2019225972A AU 2019225972 A AU2019225972 A AU 2019225972A AU 2019225972 B2 AU2019225972 B2 AU 2019225972B2
Authority
AU
Australia
Prior art keywords
ser
gly
asn
val
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019225972A
Other languages
English (en)
Other versions
AU2019225972A1 (en
Inventor
Claudia Feller
Sebastian Rissom
Thomas Stillger
Andreas Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of AU2019225972A1 publication Critical patent/AU2019225972A1/en
Application granted granted Critical
Publication of AU2019225972B2 publication Critical patent/AU2019225972B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
AU2019225972A 2018-02-22 2019-02-22 Variants of porcine trypsin Active AU2019225972B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18158034 2018-02-22
EP18158034.1 2018-02-22
PCT/EP2019/054400 WO2019162423A1 (en) 2018-02-22 2019-02-22 Variants of porcine trypsin

Publications (2)

Publication Number Publication Date
AU2019225972A1 AU2019225972A1 (en) 2020-10-15
AU2019225972B2 true AU2019225972B2 (en) 2024-10-17

Family

ID=61274085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019225972A Active AU2019225972B2 (en) 2018-02-22 2019-02-22 Variants of porcine trypsin

Country Status (13)

Country Link
US (2) US11518988B2 (enExample)
EP (1) EP3755794A1 (enExample)
JP (2) JP7432516B2 (enExample)
KR (1) KR102863070B1 (enExample)
CN (1) CN111989401A (enExample)
AU (1) AU2019225972B2 (enExample)
BR (1) BR112020016954A2 (enExample)
CA (1) CA3091943A1 (enExample)
IL (1) IL276799A (enExample)
MX (1) MX2020008766A (enExample)
MY (1) MY200951A (enExample)
SG (1) SG11202008026WA (enExample)
WO (1) WO2019162423A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019162423A1 (en) 2018-02-22 2019-08-29 Sanofi-Aventis Deutschland Gmbh Variants of porcine trypsin
CN111676211B (zh) * 2020-05-15 2022-07-19 天津科技大学 一种抗自切和高比活力胰蛋白酶突变体
CN119552847B (zh) * 2025-01-21 2025-04-11 四川大学 链霉菌胰蛋白酶自剪切位点突变体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010022452A (ko) * 1997-07-31 2001-03-15 추후제출 플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신
US7622113B2 (en) * 2003-12-08 2009-11-24 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies that bind or neutralize dengue virus
ATE517919T1 (de) * 2005-09-14 2011-08-15 Sanofi Aventis Deutschland Spaltung von insulinvorstufen durch eine trypsinvariante
BR112013009649A2 (pt) * 2010-10-29 2016-07-12 Merck Sharp & Dohme composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição
US9267114B2 (en) * 2012-11-07 2016-02-23 Southern Research Institute Flavivirus envelope protein mutations affecting virion disassembly
WO2019162423A1 (en) * 2018-02-22 2019-08-29 Sanofi-Aventis Deutschland Gmbh Variants of porcine trypsin

Also Published As

Publication number Publication date
RU2020130880A (ru) 2022-03-22
CA3091943A1 (en) 2019-08-29
US11952602B2 (en) 2024-04-09
BR112020016954A2 (pt) 2020-12-29
JP7699196B2 (ja) 2025-06-26
MX2020008766A (es) 2020-12-07
KR20200124255A (ko) 2020-11-02
US20200377873A1 (en) 2020-12-03
RU2020130880A3 (enExample) 2022-03-22
NZ768123A (en) 2026-02-27
SG11202008026WA (en) 2020-09-29
JP2021514194A (ja) 2021-06-10
KR102863070B1 (ko) 2025-09-22
AU2019225972A1 (en) 2020-10-15
JP2024038140A (ja) 2024-03-19
US20230303994A1 (en) 2023-09-28
WO2019162423A1 (en) 2019-08-29
MY200951A (en) 2024-01-25
CN111989401A (zh) 2020-11-24
EP3755794A1 (en) 2020-12-30
IL276799A (en) 2020-10-29
US11518988B2 (en) 2022-12-06
JP7432516B2 (ja) 2024-02-16

Similar Documents

Publication Publication Date Title
US11952602B2 (en) Variants of porcine trypsin
JP4344136B2 (ja) アポリポタンパク質類似体
JP6714902B2 (ja) ペプチドおよびタンパク質の発現のための方法
KR20230017804A (ko) Rhfgf21 융합 단백질, rhfgf21 융합 단백질을 인코딩하는 폴리뉴클레오티드, rhfgf21 융합 단백질을 포함하는 조성물, 및 rhfgf21 융합 단백질의 용도
EP4471138A1 (en) Iga protease truncation, fusion protein comprising iga protease truncation, and use thereof
US20170334971A1 (en) Alpha-1-Antitrypsin (A1AT) Fusion Proteins and Uses Thereof
CN111718417A (zh) 含有荧光蛋白片段的融合蛋白及其用途
Liu et al. Large scale preparation of recombinant human parathyroid hormone 1–84 from Escherichia coli
KR100989413B1 (ko) 새로운 융합파트너를 이용한 재조합 단백질의 제조방법
KR101634078B1 (ko) 봉입체 형성 단백질의 제조방법
EP4538370A1 (en) Fusion protein containing truncated iga protease and use thereof
RU2783315C2 (ru) Варианты свиного трипсина
KR100368073B1 (ko) 융합파트너를 이용한 재조합 단백질의 제조방법
KR102064810B1 (ko) 재조합 폴리펩타이드 생산용 n-말단 융합 파트너 및 이를 이용하여 재조합 폴리펩타이드를 생산하는 방법
CN112574286A (zh) 多肽及其应用
KR100407792B1 (ko) 인간 글루카곤 유사펩타이드를 융합파트너로 이용한재조합 단백질의 제조방법
KR101582655B1 (ko) 광활성 메티오닌 모사체 표지 단백질 생합성을 위한 메티오닐 tRNA 합성효소 변이체
EA052996B1 (ru) Усеченные формы iga-протеазы, слитые белки, содержащие усеченную форму iga-протеазы, и их применение

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)